Full Text
Are EU payers adapting Biosimilar Pricing and Reimbursement approval processes to Optimize Healthcare savings?

Abstract

Authors

G. Foxon G. Fox P. Craddy

Back to Volume 18, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×